Search - tctmd.com

Displaying 201 - 220 of 318

Sort: Relevancy | Date

News Daily News

High Platelet Reactivity Linked to More Adverse Events After Endovascular Procedures

Yael L. Maxwell

April 26, 2013

News Industry News

Accumetrics Obtains CE Mark for Therapeutic Window Claim on the VerifyNow P2Y12 Test

April 16, 2013

News Conference News ACC 2013

ACC/i2 2013: Controversy, Late Breaking Trial News Dominate Busy Meeting

L.A. McKeown

March 14, 2013

News Daily News

Un Subestudio del AIDA STEMI No Confirma Ventaja alguna para el Abciximab Intracoronario

February 27, 2013

News Daily News

AIDA STEMI Substudy Confirms No Advantage for Intracoronary Abciximab

February 27, 2013

News Daily News

La Atorvastatina Potencia la Eficacia del Clopidogrel en Pacintes con Alta Reactividad Plaquetaria

February 25, 2013

News Daily News

Atorvastatin Boosts Clopidogrel Efficacy in Patients with High Platelet Reactivity

February 25, 2013

Presentation TCT 2013

P2Y12 Reactivity units (PRU) to Predict Hyporesponsiveness to Clopidogrel in Patients with Chest Pain with Prior History of Coronary Artery Stenting in Emergency Department

Presenter: Rakesh Sharma, Stephen Erickson, Rohit Sharma, Hanumanth Reddy, Donald Voelker, Harvinder Dod, Vibhuti Singh, james Marsh

January 31, 2013

News Daily News

Unknowns Predominate in Variable Clopidogrel Response

January 16, 2013

News Daily News

Predominan Factores Desconocidos en la Respuesta Variable al Clopidogrel

January 16, 2013

News Daily News

Subestudio PLATO: La Ventaja del Ticagrelor Persiste tras el 1er Episodio Isquémico

January 07, 2013

News Daily News

PLATO Substudy: Ticagrelor Advantage Persists After First Ischemic Event

January 07, 2013

News Daily News

JACC Letter: Hypothermia Therapy May Increase Stent Thrombosis Risk

L.A. McKeown

January 06, 2013

News Daily News

Carta de JACC: La Terapia Hipotérmica podría Aumentar el Riesgo de Trombosis del Stent

L.A. McKeown

January 06, 2013

News Daily News

TCTMD’s Top 10 Most Popular News Stories for 2012

Jason Kahn

January 02, 2013

News Daily News

Las Noticias Más Leídas del “Top 10” de TCTMD en 2012

Jason Kahn

January 02, 2013

News Daily News

Una Dosis Alta de Aspirina tras una PCI Primaria aumenta las Hemorragias No observandose Beneficio Isquémico alguno

L.A. McKeown

December 19, 2012

News Daily News

High-Dose Aspirin After Primary PCI Increases Bleeding with No Ischemic Benefit

L.A. McKeown

December 19, 2012

News Daily News

Los Alelos Genéticos Influyen en la Respuesta al Prasugrel de los Pacientes víctimas de un SCA

Jason Kahn

December 17, 2012

News Daily News

Genetic Alleles Affect Response to Prasugrel in ACS Patients

Jason Kahn

December 17, 2012

Advertisement

High Platelet Reactivity Linked to More Adverse Events After Endovascular Procedures

Accumetrics Obtains CE Mark for Therapeutic Window Claim on the VerifyNow P2Y12 Test

ACC/i2 2013: Controversy, Late Breaking Trial News Dominate Busy Meeting

Un Subestudio del AIDA STEMI No Confirma Ventaja alguna para el Abciximab Intracoronario

AIDA STEMI Substudy Confirms No Advantage for Intracoronary Abciximab

La Atorvastatina Potencia la Eficacia del Clopidogrel en Pacintes con Alta Reactividad Plaquetaria

Atorvastatin Boosts Clopidogrel Efficacy in Patients with High Platelet Reactivity

P2Y12 Reactivity units (PRU) to Predict Hyporesponsiveness to Clopidogrel in Patients with Chest Pain with Prior History of Coronary Artery Stenting in Emergency Department

Unknowns Predominate in Variable Clopidogrel Response

Predominan Factores Desconocidos en la Respuesta Variable al Clopidogrel

Subestudio PLATO: La Ventaja del Ticagrelor Persiste tras el 1er Episodio Isquémico

PLATO Substudy: Ticagrelor Advantage Persists After First Ischemic Event

JACC Letter: Hypothermia Therapy May Increase Stent Thrombosis Risk

Carta de JACC: La Terapia Hipotérmica podría Aumentar el Riesgo de Trombosis del Stent

TCTMD’s Top 10 Most Popular News Stories for 2012

Las Noticias Más Leídas del “Top 10” de TCTMD en 2012

Una Dosis Alta de Aspirina tras una PCI Primaria aumenta las Hemorragias No observandose Beneficio Isquémico alguno

High-Dose Aspirin After Primary PCI Increases Bleeding with No Ischemic Benefit

Los Alelos Genéticos Influyen en la Respuesta al Prasugrel de los Pacientes víctimas de un SCA

Genetic Alleles Affect Response to Prasugrel in ACS Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content